Dear All: In my inbox this morning is a posting from WHO of a part-time consultancy running from 15 Oct 2018 to 14 Oct 2019 to assist with TPPs for AMR products. The description is:
The purpose of the consultancy is to assist the WHO Innovation Access and Use (IAU) Unit in the development of target product profiles (TPPs) for treatments addressing antimicrobial resistance (AMR) priority pathogens. Working closely with the WHO IAU unit, and with input from technical partners, the consultant`s role will be to prepare background documentation on TPPs for AMR priority pathogens, develop and draft the TPPs and support the management of experts meetings and inputs related to the development of the TPPs following an agreed WHO methodology.
Could this be right for you? The application period ends on 20 Sep, so you’ll need to move quickly if this is of interest.
All best wishes, –jr
John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: https://13.43.35.2/blog/
Opportunities of interest for the AMR community
- 20 Sep 2018 deadline: Part-time role at WHO to assist in developing TPPs for treatments addressing AMR pathogens. Details here.
- 11 Oct 2018 deadline: Novo’s REPAIR Impact fund has re-opened for proposals during the window 4 Sep – 11 Oct. Read more and apply here.
- 24 Oct 2018 deadline: IMI AMR Accelerator programme Pillar A within IMI Call 15: Capability-building network to manage the whole accelerator and strengthen AMR science. This is a two-stage call, with letter of intent from applicants expected on 24 Oct 2018.
- 24 Oct 2018 deadline: IMI AMR Accelerator programme Pillar B: Tuberculosis drug development network within IMI Call 15: Tuberculosis drug development network to collaboratively progress TB compounds and validate new tools for TB drug development. This is a two-stage call, with letter of intent from applicants expected on 24 Oct 2018.
- 24 Oct 2018 deadline: IMI Call 16: A series of individual programs where a single EFPIA partner works with a consortium to progress compounds for for TB, non-tuberculous mycobacteria, and Gram-negatives. This is a one-stage call, with full proposal from the EFPIA and applicant consortium expected on 24 Oct 2018.
Upcoming meetings of interest to the AMR community:
- 17 Sep 2018 (Washington): NIAID workshop entitled “Science and Regulation of Live Microbiome-Based Products Used to Prevent, Treat, or Cure Diseases in Humans.” More details and registration are here.
- [NEW] 23-26 Sep 2018 (Washington, DC): ASM Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines.
- 24-28 Sep 2018 (Big Sky, Montana): MSG-ERC (Mycoses Study Group) Biennal meeting
- 25 Sep 2018 (New York City): UN General Assembly side-event entitled “Launch of the AMR Challenge.” Sponsored by CDC, BMGF, Pew, Wellcome, and the UN foundation, this is a kick-off event for a year-long effort to encourage commitments to tackling the AMR problem.
- 26 Sep 2018 (Columbus, OH): Open meeting of PACCARB. The available data about the meeting are found here.
- 28 Sep 2018 (New York City): New York Academy of Sciences workshop entitled “Minimizing the Risk of Antimicrobial Resistance from Food Animal Production”
- 3-7 Oct 2018 (San Francisco): ID Week
- 6-14 Oct 2018 International Course on Antibiotics and Resistance (ICARe, Les Pensières, Annecy, France)
- 23 Oct 2018 (New York City): New York Academy of Sciences workshop entitled “New Therapeutic Strategies to Combat Antibacterial Resistance“
- 26 Oct 2018 (London): EMA information day for SMEs: “Regulatory toolbox for medicines and combined devices developers”. Here is the current agenda. Webcast will be available. More details from sme@ema.europa.eu.
- 29-30 Oct 2018 (Washington: BARDA Industry Days, a 2-day conference on countermeasure development for the US Government
- 7-9 Nov 2018 (Seville, Spain): Better Methods for Clinical Studies in Infectious Diseases and Clinical Microbiology: A Hands-on Workshop
- 8 Nov 2018 (Alderley Park, UK): Bionow’s 1-day Bioinfect conference
- 13 Nov 2018 (London): All-Parties Parliamentary Working Group on AMR meeting. Online materials here.
- 16 Nov 2018 (Berlin): Max Planck Institute for Innovation and Competition is organizing a conference on life sciences and innovation. Online materials here.
- 29-30 Nov 2018 (Birmingham, UK): BSAC (British Society Antimicrobial Chemotherapy): Antibiotic Resistance Mechanisms Workshop for Researchers.
- 14-15 Mar 2019 (Berlin): BEAM– and ND4BB-ENABLE-sponsored Berlin Conference on Novel Antimicrobials and AMR Diagnostics. Details here.
- 21-22 Mar 2019 (Birmingham, UK): BSAC Spring Conference.